cystamine has been researched along with Nerve Degeneration in 2 studies
Nerve Degeneration: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The present study investigated tTG expression after ICH and the effects of a tTG inhibitor, cystamine, on ICH-induced brain edema and neurological deficits." | 7.75 | Tissue-type transglutaminase and the effects of cystamine on intracerebral hemorrhage-induced brain edema and neurological deficits. ( Hua, Y; Keep, RF; Okauchi, M; Xi, G, 2009) |
| " The present study investigated tTG expression after ICH and the effects of a tTG inhibitor, cystamine, on ICH-induced brain edema and neurological deficits." | 3.75 | Tissue-type transglutaminase and the effects of cystamine on intracerebral hemorrhage-induced brain edema and neurological deficits. ( Hua, Y; Keep, RF; Okauchi, M; Xi, G, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okauchi, M | 1 |
| Xi, G | 1 |
| Keep, RF | 1 |
| Hua, Y | 1 |
| Bortvedt, SF | 1 |
| McLear, JA | 1 |
| Messer, A | 1 |
| Ahern-Rindell, AJ | 1 |
| Wolfgang, WJ | 1 |
2 other studies available for cystamine and Nerve Degeneration
| Article | Year |
|---|---|
Tissue-type transglutaminase and the effects of cystamine on intracerebral hemorrhage-induced brain edema and neurological deficits.
Topics: Animals; Basal Ganglia; Blotting, Western; Brain Chemistry; Brain Edema; Cerebral Hemorrhage; Cystam | 2009 |
Cystamine and intrabody co-treatment confers additional benefits in a fly model of Huntington's disease.
Topics: Animals; Animals, Genetically Modified; Antibodies; Cystamine; Disease Models, Animal; Drosophila me | 2010 |